Venous hemodynamics in neurological disorders: An analytical review with hydrodynamic analysis

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Beggs, Clive B ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

CCSVI; Cerebral blood flow; Cerebrospinal fluid; Leukoaraiosis; Multiple sclerosis; Normal pressure hydrocephalus; Venous hypertension

Indexed keywords

BRAIN BLOOD FLOW; BRAIN HYPOXIA; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID FLOW; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; HEMODYNAMICS; HUMAN; HYDRODYNAMICS; HYPERTENSION; LEUKOARAIOSIS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; HEMODYNAMICS; HUMANS; HYDRODYNAMICS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; VENOUS INSUFFICIENCY;

EID: 84878372031     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-142     Document Type: Review

References (202)

1. Frydrychowski AF, Winklewski PJ, Guminski W. Influence of acute jugular vein compression on the cerebral blood flow velocity, pial artery pulsation and width of subarachnoid space in humans. PLoS One 2012, 7:e48245. 10.1371/journal.pone.0048245, 3480498, 23110218.
2. Bateman GA. The pathophysiology of idiopathic normal pressure hydrocephalus: cerebral ischemia or altered venous hemodynamics?. AJNR Am J Neuroradiol 2008, 29:198-203. 10.3174/ajnr.A0739, 17925373.
3. Bateman GA. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal-pressure hydrocephalus. Neuroradiology 2002, 44:740-748. 10.1007/s00234-002-0812-0, 12221445.
4. Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojanacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F, Zivadinov R. The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol 2009, 24:133-138.
5. Bateman GA, Levi CR, Schofield P, Wang Y, Lovett EC. The venous manifestations of pulse wave encephalopathy: windkessel dysfunction in normal aging and senile dementia. Neuroradiology 2008, 50:491-497. 10.1007/s00234-008-0374-x, 18379767.
6. Putnam TJ, Adler A. Vascular architecture of the lesions of multiple sclerosis. Arch Neurol Psychiat 1937, 38:1-5.
7. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80:392-399. 2647682, 19060024.
8. Zamboni P, Menegatti E, Conforti P, Shepherd S, Tessari M, Beggs C. Assessment of cerebral venous return by a novel plethysmography method. J Vasc Surg 2012, 56:677-685. 10.1016/j.jvs.2012.01.074, 22521804.
9. Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B. Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol 2011, 11:128. 10.1186/1471-2377-11-128, 3210082, 22011402.
10. Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edinb 1916, 50:517.
11. Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Psychiatry 1937, 6:1298-1321.
12. Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007, 257:62-66. 10.1016/j.jns.2007.01.015, 1989116, 17320909.
13. Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology 1995, 194:469-476.
14. Brown WR, Moody DM, Thore CR, Anstrom JA, Challa VR. Microvascular changes in the white mater in dementia. J Neurol Sci 2009, 283:28-31. 10.1016/j.jns.2009.02.328, 2713367, 19268311.
15. Chung CP, Hu HH. Pathogenesis of leukoaraiosis: role of jugular venous reflux. Med Hypotheses 2010, 75:85-90. 10.1016/j.mehy.2010.01.042, 20172657.
16. Chung CP, Wang PN, Wu YH, Tsao YC, Sheng WY, Lin KN, Lin SJ, Hu HH. More severe white matter changes in the elderly with jugular venous reflux. Ann Neurol 2011, 69:553-559. 10.1002/ana.22276, 21391231.
17. Bateman GA. Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus. Med Hypotheses 2004, 62:182-187. 10.1016/S0306-9877(03)00330-X, 14962623.
18. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004, 231:645-652. 10.1148/radiol.2313030996, 15163806.
19. Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 2005, 26:1539-1547.
20. Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009, 282:28-33. 10.1016/j.jns.2008.12.036, 2737614, 19181347.
21. Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. NeuroImage 2006, 33:1029-1035. 10.1016/j.neuroimage.2006.08.008, 1752216, 16996280.
22. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann N Y Acad Sci 1997, 826:103-116. 10.1111/j.1749-6632.1997.tb48464.x, 9329684.
23. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011, 37:56-74. 10.1111/j.1365-2990.2010.01139.x, 3020267, 20946471.
24. Dalton CM, Brex PA, Jenkins R, Fox NC, Miszkiel KA, Crum WR, O'Riordan JI, Plant GT, Thompson AJ, Miller DH. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002, 73:141-147. 10.1136/jnnp.73.2.141, 1737988, 12122170.
25. Dalton CM, Miszkiel KA, O'Connor PW, Plant GT, Rice GP, Miller DH. Ventricular enlargement in MS: one-year change at various stages of disease. Neurology 2006, 66:693-698. 10.1212/01.wnl.0000201183.87175.9f, 16534105.
26. Bradley WG. Normal pressure hydrocephalus: new concepts on etiology and diagnosis. AJNR Am J Neuroradiol 2000, 21:1586-1590.
27. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998, 19:1277-1284.
28. Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Giannini S. Gait abnormalities in minimally impaired multiple sclerosis patients. Mult Scler 1999, 5:363-368.
29. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997, 45:1434-1438.
30. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999, 67:658-660. 10.1136/jnnp.67.5.658, 1736610, 10519875.
31. Mori E. Gait disturbance in idiopathic normal pressure hydrocephalus. Brain Nerve 2008, 60:219-224.
32. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008, 7:1139-1151. 10.1016/S1474-4422(08)70259-X, 19007738.
33. Saito M, Nishio Y, Kanno S, Uchiyama M, Hayashi A, Takagi M, Kikuchi H, Yamasaki H, Shimomura T, Iizuka O, Mori E. Cognitive profile of idiopathic normal pressure hydrocephalus. Dement Geriatr Cogn Dis Extra 2011, 1:202-211. 10.1159/000328924, 3199897, 22163245.
34. Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80:470-477.
35. Sakakibara R, Kanda T, Sekido T, Uchiyama T, Awa Y, Ito T, Liu Z, Yamamoto T, Yamanishi T, Yuasa T, Shirai K, Hattori T. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn 2008, 27:507-510. 10.1002/nau.20547, 18092331.
36. Ge Y, Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL. Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 2001, 220:606-610. 10.1148/radiol.2203001776, 11526256.
37. Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000, 214:665-670.
38. Bradley WG, Whittemore AR, Kortman KE, Watanabe AS, Homyak M, Teresi LM, Davis SJ. Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. Radiology 1991, 178:459-466.
39. Bradley WG. Cerebrospinal fluid dynamics and shunt responsiveness in patients with normal-pressure hydrocephalus. Mayo Clin Proc 2002, 77:507-508. 10.4065/77.6.507, 12059118.
40. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004, 75:441-447. 10.1136/jnnp.2003.014910, 1738975, 14966162.
41. Bruck W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 2005, 252:v3-v9. 10.1007/s00415-005-5002-7, 16254699.
42. Fernandez M, Giuliani A, Pirondi S, D'Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A 2004, 101:16363-16368. 10.1073/pnas.0407262101, 526198, 15534218.
43. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A 2010, 107:11555-11560. 10.1073/pnas.1006496107, 2895128, 20534434.
44. Schwartz GL, Fornage M, Mosley T, Turner ST. Treatment of leukoaraiosis. Curr Treat Options Cardiovasc Med 2005, 7:173-177. 10.1007/s11936-005-0045-8, 16004848.
45. Fog T. On the vessel-plaque relations in the brain in multiple sclerosis. Acta Neurol Scand Suppl 1963, 39:258-262.
46. Schelling F. Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses 1986, 21:141-148. 10.1016/0306-9877(86)90003-4, 3641027.
47. Talbert DG. Raised venous pressure as a factor in multiple sclerosis. Med Hypotheses 2008, 70:1112-1117. 10.1016/j.mehy.2007.10.009, 18079069.
48. Adams CW, Abdulla YH, Torres EM, Poston RN. Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurobiol 1987, 13:141-152. 10.1111/j.1365-2990.1987.tb00177.x, 3614542.
49. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988, 51:260-265. 10.1136/jnnp.51.2.260, 1031540, 3346691.
50. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122:17-26. 10.1093/brain/122.1.17, 10050891.
51. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990, 113:1477-1489. 10.1093/brain/113.5.1477, 2245307.
52. Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000, 21:1039-1042.
53. Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, Evangelou N. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 2011, 76:534-539. 10.1212/WNL.0b013e31820b7630, 3053180, 21300968.
54. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981, 7:519-579. 10.1016/0361-9230(81)90007-1, 7317796.
55. Gilmore CP, Donaldson I, Bo L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009, 80:182-187. 10.1136/jnnp.2008.148767, 18829630.
56. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010, 133:333-348. 10.1093/brain/awp321, 2822631, 20129932.
57. Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, Rammohan K, Knopp MV, Schmalbrock P. Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010, 67:812-818. 10.1001/archneurol.2010.148, 20625086.
58. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747. 10.1146/annurev.immunol.23.021704.115707, 15771584.
59. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10:153-187. 10.1146/annurev.iy.10.040192.001101, 1375472.
60. D'Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. Lancet Neurol 2011, 10:657-666. 10.1016/S1474-4422(11)70105-3, 21683931.
61. De Keyser J, Steen C, Mostert JP, Koch MW. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 2008, 28:1645-1651. 10.1038/jcbfm.2008.72, 18594554.
62. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003, 206:187-191. 10.1016/S0022-510X(02)00421-5, 12559509.
63. Al-Omari MH, Rousan LA. Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. Int Angiol 2010, 29:115-120.
64. Beggs C, Shepherd S, Zamboni P. Cerebral venous outflow resistance and interpretation of cervical plethysmography data with respect to the diagnosis of chronic cerebrospinal venous insufficiency. Phlebology 2012, Epub ahead of print.
65. Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Med 2011, 9:22. 10.1186/1741-7015-9-22, 3059278, 21385345.
66. Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H, Herbert J, Haacke EM, Grossman RI. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 2009, 29:1190-1194. 10.1002/jmri.21758, 2818352, 19388109.
67. Beggs CB, Shepherd SJ, Dwyer MG, Polak P, Magnano C, Carl E, Poloni G, Weinstein-Guttman B, Zivadinov R. Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis. Neurol Res 2012, 34:793-801. 10.1179/1743132812Y.0000000048, 22709857.
68. Brooks DJ, Leenders KL, Head G, Marshall J, Legg NJ, Jones T. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry 1984, 47:1182-1191. 10.1136/jnnp.47.11.1182, 1028084, 6334132.
69. Lycke J, Wikkelso C, Bergh AC, Jacobsson L, Andersen O. Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime. Eur Neurol 1993, 33:163-167. 10.1159/000116926, 8467826.
70. Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S. Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med 1998, 12:89-94. 10.1007/BF03164835, 9637279.
71. Swank RL, Roth JG, Woody DC. Cerebral blood flow and red cell delivery in normal subjects and in multiple sclerosis. Neurol Res 1983, 5:37-59.
72. Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, Altmann DR, Symms MR, Tofts PS, Thompson AJ, Miller DH. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004, 75:1288-1293. 10.1136/jnnp.2003.026021, 1739228, 15314117.
73. Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008, 28:164-171. 10.1038/sj.jcbfm.9600504, 2596621, 17473851.
74. Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Salvatore E, Brunetti A, Iaccarino V, Salvatore M. Multiple sclerosis: cerebral circulation time. Radiology 2012, 262:947-955. 10.1148/radiol.11111239, 22357894.
75. Cutler RW, Page L, Galicich J, Watters GV. Formation and absorption of cerebrospinal fluid in man. Brain 1968, 91:707-720. 10.1093/brain/91.4.707, 5304069.
76. Ekstedt J. CSF hydrodynamic studies in man. 2. Normal hydrodynamic variables related to CSF pressure and flow. J Neurol Neurosurg Psychiatry 1978, 41:345-353. 10.1136/jnnp.41.4.345, 493028, 650242.
77. Magnano C, Schirda C, Weinstock-Guttman B, Wack DS, Lindzen E, Hojnacki D, Bergsland N, Kennedy C, Belov P, Dwyer MG, Poloni GU, Beggs CB, Zivadinov R. Cine cerebrospinal fluid imaging in multiple sclerosis. J Magn Reson Imaging 2012, 36:825-834. 10.1002/jmri.23730, 22733409.
78. Popescu BF, Lucchinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012, 12:11. 10.1186/1471-2377-12-11, 3315403, 22397318.
79. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?. J Neurol Sci 2006, 245:123-126. 10.1016/j.jns.2005.09.021, 16650874.
80. Helenius J, Soinne L, Salonen O, Kaste M, Tatlisumak T. Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke 2002, 33:45-50. 10.1161/hs0102.101228, 11779887.
81. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993, 50:818-824. 10.1001/archneur.1993.00540080029009, 8352667.
82. van Gijn J. Leukoaraiosis and vascular dementia. Neurology 1998, 51:S3-S8. 10.1212/WNL.51.3_Suppl_3.S3, 9744823.
83. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991, 22:609-614. 10.1161/01.STR.22.5.609, 2028490.
84. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L. Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry 1997, 62:177-181. 10.1136/jnnp.62.2.177, 486730, 9048719.
85. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weathers S. Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993, 56:182-187. 10.1136/jnnp.56.2.182, 1014819, 8437007.
86. Simon J. Ischemia and multiple sclerosis: perfusion MR imaging provides insight into an underexplored pathophysiology. AJNR Am J Neuroradiol 2005, 26:1306-1308.
87. Jack CR, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, Manduca A, Avula R, Erickson BJ. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001, 14:668-676. 10.1002/jmri.10011, 2755497, 11747022.
88. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659. 10.1161/01.STR.28.3.652, 9056627.
89. Inzitari D, Mascalchi M, Giordano GP, Marini P, Sita D, Abbamondi AL. Histopathological correlates of leuko-araiosis in patients with ischemic stroke. Eur Neurol 1989, 29:23-26.
90. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, Markus HS. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002, 59:321-326. 10.1212/WNL.59.3.321, 12177363.
91. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000, 69:48-53. 10.1136/jnnp.69.1.48, 1737001, 10864603.
92. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H. Vascular risk factors and leuko-araiosis. Arch Neurol 1987, 44:42-47. 10.1001/archneur.1987.00520130034014, 3800721.
93. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990, 21:1419-1423. 10.1161/01.STR.21.10.1419, 2219206.
94. Wiszniewska M, Devuyst G, Bogousslavsky J, Ghika J, van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke?. Arch Neurol 2000, 57:967-973. 10.1001/archneur.57.7.967, 10891978.
95. Furuta A, Ishii N, Nishihara Y, Horie A. Medullary arteries in aging and dementia. Stroke 1991, 22:442-446. 10.1161/01.STR.22.4.442, 2024272.
96. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:1683-1689. 10.1212/WNL.43.9.1683, 8414012.
97. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991, 114:761-774. 10.1093/brain/114.2.761, 2043948.
98. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002, 203-204:159-163.
99. Moody DM, Santamore WP, Bell MA. Does tortuosity in cerebral arterioles impair down-autoregulation in hypertensives and elderly normotensives? A hypothesis and computer model. Clin Neurosurg 1991, 37:372-387.
100. Thore CR, Anstrom JA, Moody DM, Challa VR, Marion MC, Brown WR. Morphometric analysis of arteriolar tortuosity in human cerebral white matter of preterm, young, and aged subjects. J Neuropathol Exp Neurol 2007, 66:337-345. 10.1097/nen.0b013e3180537147, 17483690.
101. Chung CP, Lin YJ, Chao AC, Lin SJ, Chen YY, Wang YJ, Hu HH. Jugular venous hemodynamic changes with aging. Ultrasound Med Biol 2010, 36:1776-1782. 10.1016/j.ultrasmedbio.2010.07.006, 20800950.
102. Bateman GA. Vascular compliance in normal pressure hydrocephalus. AJNR Am J Neuroradiol 2000, 21:1574-1585.
103. Bateman GA. Vascular hydraulics associated with idiopathic and secondary intracranial hypertension. AJNR Am J Neuroradiol 2002, 23:1180-1186.
104. Guyton AC, Hall JE. Textbook of Medical Physiology 2000, Philadelphia: Saunders, 10.
105. Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a review. AJR Am J Roentgenol 2000, 174:1657-1665. 10.2214/ajr.174.6.1741657, 10845502.
106. Kiefer M, Unterberg A. The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int 2012, 109:15-25. quiz 26, 3265984, 22282714.
107. Tsunoda A, Mitsuoka H, Bandai H, Endo T, Arai H, Sato K. Intracranial cerebrospinal fluid measurement studies in suspected idiopathic normal pressure hydrocephalus, secondary normal pressure hydrocephalus, and brain atrophy. J Neurol Neurosurg Psychiatry 2002, 73:552-555. 10.1136/jnnp.73.5.552, 1738128, 12397150.
108. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965, 2:307-327. 10.1016/0022-510X(65)90016-X, 5889177.
109. Hankey GJ, Wardlaw JM. Clinical Neurology 2002, London: Manson Publishing.
110. Bateman GA. The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion. Neuroradiology 2003, 45:65-70.
111. Egnor M, Zheng L, Rosiello A, Gutman F, Davis R. A model of pulsations in communicating hydrocephalus. Pediatr Neurosurg 2002, 36:281-303. 10.1159/000063533, 12077474.
112. El Sankari S, Gondry-Jouet C, Fichten A, Godefroy O, Serot JM, Deramond H, Meyer ME, Baledent O. Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2011, 8:12. 10.1186/2045-8118-8-12, 3045982, 21349149.
113. Miyati T, Mase M, Kasai H, Hara M, Yamada K, Shibamoto Y, Soellinger M, Baltes C, Luechinger R. Noninvasive MRI assessment of intracranial compliance in idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2007, 26:274-278. 10.1002/jmri.20999, 17610284.
114. Mase M, Miyati T, Kasai H, Demura K, Osawa T, Hara M, Shibamoto Y, Yamada K. Noninvasive estimation of intracranial compliance in idiopathic NPH using MRI. Acta Neurochir Suppl 2008, 102:115-118. 10.1007/978-3-211-85578-2_23, 19388300.
115. Williams H. The venous hypothesis of hydrocephalus. Med Hypotheses 2008, 70:743-747. 10.1016/j.mehy.2007.08.013, 17919832.
116. Williams H. A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida. Cerebrospinal Fluid Res 2008, 5:7. 10.1186/1743-8454-5-7, 2365936, 18405364.
117. Rekate HL. A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics. Childs Nerv Syst 2011, 27:1535-1541. 10.1007/s00381-011-1558-y, 3175041, 21928019.
118. Bradley WG. Idiopathic normal pressure hydrocephalus: new findings and thoughts on etiology. AJNR Am J Neuroradiol 2008, 29:1-3.
119. Nakahara Y, Ogata A, Takase Y, Maeda K, Okamoto H, Matsushima T, Sakata S. Treatment of dural arteriovenous fistula presenting as typical symptoms of hydrocephalus caused by venous congestion: case report. Neurol Med Chir (Tokyo) 2011, 51:229-232.
120. Graff-Radford NR, Rezai K, Godersky JC, Eslinger P, Damasio H, Kirchner PT. Regional cerebral blood flow in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1987, 50:1589-1596. 10.1136/jnnp.50.12.1589, 1032599, 3501800.
121. Owler BK, Momjian S, Czosnyka Z, Czosnyka M, Péna A, Harris NG, Smielewski P, Fryer T, Donovan T, Coles J, Carpenter A, Pickard JD. Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values. J Cereb Blood Flow Metab 2004, 24:17-23.
122. Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 2004, 127:965-972. 10.1093/brain/awh131, 15033897.
123. Larsson A, Bergh AC, Bilting M, Arlig A, Jacobsson L, Stephensen H, Wikkelso C. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994, 21:118-123.
124. Tullberg M, Jensen C, Ekholm S, Wikkelso C. Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am J Neuroradiol 2001, 22:1665-1673.
125. Luetmer PH, Huston J, Friedman JA, Dixon GR, Petersen RC, Jack CR, McClelland RL, Ebersold MJ. Measurement of cerebrospinal fluid flow at the cerebral aqueduct by use of phase-contrast magnetic resonance imaging: technique validation and utility in diagnosing idiopathic normal pressure hydrocephalus. Neurosurgery 2002, 50:534-543. discussion 543-534.
126. Schroth G, Klose U. Cerebrospinal fluid flow. III. Pathological cerebrospinal fluid pulsations. Neuroradiology 1992, 35:16-24. 10.1007/BF00588272, 1289733.
127. Gideon P, Stahlberg F, Thomsen C, Gjerris F, Sorensen PS, Henriksen O. Cerebrospinal fluid flow and production in patients with normal pressure hydrocephalus studied by MRI. Neuroradiology 1994, 36:210-215. 10.1007/BF00588133, 8041442.
128. Kim DS, Choi JU, Huh R, Yun PH, Kim DI. Quantitative assessment of cerebrospinal fluid hydrodynamics using a phase-contrast cine MR image in hydrocephalus. Childs Nerv Syst 1999, 15:461-467. 10.1007/s003810050440, 10502007.
129. Bradley WG, Scalzo D, Queralt J, Nitz WN, Atkinson DJ, Wong P. Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. Radiology 1996, 198:523-529.
130. Tullberg M, Mansson JE, Fredman P, Lekman A, Blennow K, Ekman R, Rosengren LE, Tisell M, Wikkelso C. CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. J Neurol Neurosurg Psychiatry 2000, 69:74-81. 10.1136/jnnp.69.1.74, 1737023, 10864607.
131. McCormick JM, Yamada K, Rekate HL, Miyake H. Time course of intraventricular pressure change in a canine model of hydrocephalus: its relationship to sagittal sinus elastance. Pediatr Neurosurg 1992, 18:127-133. 10.1159/000120650, 1457371.
132. Olivero WC, Rekate HL, Chizeck HJ, Ko W, McCormick JM. Relationship between intracranial and sagittal sinus pressure in normal and hydrocephalic dogs. Pediatr Neurosci 1988, 14:196-201. 10.1159/000120388, 3269540.
133. Algin O, Hakyemez B, Ocakoglu G, Parlak M. MR cisternography: is it useful in the diagnosis of normal-pressure hydrocephalus and the selection of "good shunt responders"?. Diagn Interv Radiol 2011, 17:105-111.
134. Tator CH, Fleming JF, Sheppard RH, Turner VM. A radioisotopic test for communicating hydrocephalus. J Neurosurg 1968, 28:327-340. 10.3171/jns.1968.28.4.0327, 5300463.
135. Wuerfel J, Paul F, Zipp F. Cerebral blood perfusion changes in multiple sclerosis. J Neurol Sci 2007, 259:16-20. 10.1016/j.jns.2007.02.011, 17382348.
136. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
137. Hulst HE, Geurts JJ. Gray matter imaging in multiple sclerosis: what have we learned?. BMC Neurol 2011, 11:153. 10.1186/1471-2377-11-153, 3262750, 22152037.
138. Minagar A, Alexander SJ. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9:540-549. 10.1191/1352458503ms965oa, 14664465.
139. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003, 201:319-327. 10.1002/path.1434, 14517850.
140. Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994, 47:129-133. 10.1136/jcp.47.2.129, 501826, 8132826.
141. Aboul-Enein F, Lassmann H. Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?. Acta Neuropathol 2005, 109:49-55. 10.1007/s00401-004-0954-8, 15645261.
142. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 2008, 65:812-816. 10.1001/archneur.65.6.812, 2579786, 18541803.
143. Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, MacManus DG, Thompson AJ, Miller DH. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000, 123:1667-1676. 10.1093/brain/123.8.1667, 10908196.
144. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, Zipp F. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004, 127:111-119. 10.1093/brain/awh007, 14570816.
145. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 2010, 30:1625-1636. 10.1038/jcbfm.2010.29, 2949263, 20234382.
146. Witt KA, Mark KS, Hom S, Davis TP. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 2003, 285:H2820-H2831.
147. Witt KA, Mark KS, Sandoval KE, Davis TP. Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res 2008, 75:91-96. 10.1016/j.mvr.2007.06.004, 2243179, 17651765.
148. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002, 12:154-169.
149. Leech S, Kirk J, Plumb J, McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 2007, 33:86-98.
150. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990, 11:273-281.
151. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis. J Neurol Sci 2006, 245:3-7. 10.1016/j.jns.2005.06.018, 16626755.
152. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 2003, 13:554-573.
153. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton SB, Shaw PJ, O'Brien JT, Ince PG, MRC Cognitive Function and Ageing Neuropathology Study Group White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006, 37:1391-1398. 10.1161/01.STR.0000221308.94473.14, 16627790, MRC Cognitive Function and Ageing Neuropathology Study Group.
154. ten Dam VH, van den Heuvel DM, de Craen AJ, Bollen EL, Murray HM, Westendorp RG, Blauw GJ, van Buchem MA. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology 2007, 243:198-203. 10.1148/radiol.2431052111, 17329688.
155. Schlesinger B. The venous drainage of the brain, with special reference to the galenic system. Brain 1939, 62:274-291.
156. San Millan Ruiz D, Delavelle J, Yilmaz H, Gailloud P, Piovan E, Bertramello A, Pizzini F, Rufenacht DA. Parenchymal abnormalities associated with developmental venous anomalies. Neuroradiology 2007, 49:987-995. 10.1007/s00234-007-0279-0, 17703296.
157. Dillon WP. Cryptic vascular malformations: controversies in terminology, diagnosis, pathophysiology, and treatment. AJNR Am J Neuroradiol 1997, 18:1839-1846.
158. Luce JM, Huseby JS, Kirk W, Butler J. A Starling resistor regulates cerebral venous outflow in dogs. J Appl Physiol 1982, 53:1496-1503.
159. Vignes JR, Dagain A, Guerin J, Liguoro D. A hypothesis of cerebral venous system regulation based on a study of the junction between the cortical bridging veins and the superior sagittal sinus. Laboratory investigation. J Neurosurg 2007, 107:1205-1210. 10.3171/JNS-07/12/1205, 18077958.
160. Holt JP. The collapse factor in the measurement of venous pressure. Am J Physiol 1941, 134:292-299.
161. Katz AI, Chen Y, Moreno AH. Flow through a collapsible tube. Experimental analysis and mathematical model. Biophys J 1969, 9:1261-1279. 10.1016/S0006-3495(69)86451-9, 1367519, 5824415.
162. Lyon CK, Scott JB, Anderson DK, Wang CY. Flow through collapsible tubes at high Reynolds numbers. Circ Res 1981, 49:988-996. 10.1161/01.RES.49.4.988, 7273367.
163. Lyon CK, Scott JB, Wang CY. Flow through collapsible tubes at low Reynolds numbers. Applicability of the waterfall model. Circ Res 1980, 47:68-73. 10.1161/01.RES.47.1.68, 7379268.
164. Schaller B. Physiology of cerebral venous blood flow: from experimental data in animals to normal function in humans. Brain Res Brain Res Rev 2004, 46:243-260. 10.1016/j.brainresrev.2004.04.005, 15571768.
165. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009, 50:1348-1358. e1341-1343, 10.1016/j.jvs.2009.07.096, 19958985.
166. Egnor M, Rosiello A, Zheng L. A model of intracranial pulsations. Pediatr Neurosurg 2001, 35:284-298. 10.1159/000050440, 11786696.
167. Wagshul ME, Eide PK, Madsen JR. The pulsating brain: a review of experimental and clinical studies of intracranial pulsatility. Fluids Barriers CNS 2011, 8:5. 10.1186/2045-8118-8-5, 3042979, 21349153.
168. Kim J, Thacker NA, Bromiley PA, Jackson A. Prediction of the jugular venous waveform using a model of CSF dynamics. AJNR Am J Neuroradiol 2007, 28:983-989.
169. Ambarki K, Baledent O, Kongolo G, Bouzerar R, Fall S, Meyer ME. A new lumped-parameter model of cerebrospinal hydrodynamics during the cardiac cycle in healthy volunteers. IEEE Trans Biomed Eng 2007, 54:483-491.
170. Alperin N, Vikingstad EM, Gomez-Anson B, Levin DN. Hemodynamically independent analysis of cerebrospinal fluid and brain motion observed with dynamic phase contrast MRI. Magn Reson Med 1996, 35:741-754. 10.1002/mrm.1910350516, 8722826.
171. Kitano M, Oldendorf WH, Cassen B. The elasticity of the cranial blood pool. J Nucl Med 1964, 5:613-625.
172. Zamboni P, Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010, 25:269-279. 10.1258/phleb.2010.009083, 21106999.
173. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010, 68:173-183.
174. Beggs CB. Multiple sclerosis appears to be associated with cerebral venous abnormalities. Ann Neurol 2010, 68:560-561. 10.1002/ana.22159, 20976772.
175. Doepp F, Wurfel JT, Pfueller CF, Valdueza JM, Petersen D, Paul F, Schreiber SJ. Venous drainage in multiple sclerosis: a combined MRI and ultrasound study. Neurology 2011, 77:1745-1751. 10.1212/WNL.0b013e318236f0ea, 22031530.
176. Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U. The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry 2011, 82:436-440. 10.1136/jnnp.2010.231613, 3061048, 21296899.
177. Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, Trapp B, Bar-Or A, Zak I, Siegel MJ, Lisak R. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol 2010, 67:286-290. 10.1002/ana.22001, 20373339.
178. Wattjes MP, Doepp F, Bendszus M, Fiehler J. Chronic cerebrospinal venous insufficiency" in multiple sclerosis - is multiple sclerosis a disease of the cerebrospinal venous outflow system?. Rofo 2011, 183:523-530. 10.1055/s-0031-1273292, 21487978.
179. Baracchini C, Atzori M, Gallo P. CCSVI and MS: no meaning, no fact. Neurol Sci 2012, Epub ahead of print.
180. Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D, Weinstock-Guttman B. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology 2011, 77:138-144. 10.1212/WNL.0b013e318212a901, 21490322.
181. Simka M, Kostecki J, Zaniewski M, Majewski E, Hartel M. Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol 2010, 29:109-114.
182. Zaniewski M, Kostecki J, Kuczmik W, Ziaja D, Opala G, Swiat M, Korzeniowski T, Majewski E, Urbanek T, Pawlicki K. Neck duplex Doppler ultrasound evaluation for assessing chronic cerebrospinal venous insufficiency in multiple sclerosis patients. Phlebology 2012, Epub ahead of print.
183. Utriainen D, Feng W, Elias S, Latif Z, Hubbard D, Haacke EM. Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients. Tech Vasc Interv Radiol 2012, 15:101-112. 10.1053/j.tvir.2012.02.003, 22640499.
184. Haacke EM, Feng W, Utriainen D, Trifan G, Wu Z, Latif Z, Katkuri Y, Hewett J, Hubbard D. Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins. J Vasc Interv Radiol 2012, 23:60-68. e61-63, 10.1016/j.jvir.2011.09.027, 22221473.
185. Yamout B, Herlopian A, Issa Z, Habib RH, Fawaz A, Salame J, Wadih A, Awdeh H, Muallem N, Raad R, Al-Kutoubi A. Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler 2010, 16:1341-1348. 10.1177/1352458510385268, 21041329.
186. Bastianello S, Romani A, Viselner G, Tibaldi EC, Giugni E, Altieri M, Cecconi P, Mendozzi L, Farina M, Mariani D, Galassi A, Quattrini C, Mancini M, Bresciamorra V, Lagace A, McDonald S, Bono G, Bergamaschi R. Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study. BMC Neurol 2011, 11:132. 10.1186/1471-2377-11-132, 3221625, 22029656.
187. Krogias C, Schroder A, Wiendl H, Hohlfeld R, Gold R. Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients. Nervenarzt 2010, 81:740-746. 10.1007/s00115-010-2972-1, 20386873.
188. Baracchini C, Perini P, Causin F, Calabrese M, Rinaldi F, Gallo P. Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology 2011, 77:844-850. 10.1212/WNL.0b013e31822c6208, 21849656.
189. Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den Berg R, Uitdehaag BM, Polman CH, Barkhof F. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry 2011, 82:429-435. 10.1136/jnnp.2010.223479, 20980483.
190. Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 2010, 68:255-259. 10.1002/ana.22132, 20695018.
191. Centonze D, Floris R, Stefanini M, Rossi S, Fabiano S, Castelli M, Marziali S, Spinelli A, Motta C, Garaci FG, Bernardi G, Simonetti G. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol 2011, 70:51-58.
192. Laupacis A, Lillie E, Dueck A, Straus S, Perrier L, Burton JM, Aviv R, Thorpe K, Feasby T, Spears J. Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis. CMAJ 2011, 183:E1203-E1212. 10.1503/cmaj.111074, 3216446, 21969411.
193. Parvey HR, Eisenberg RL, Giyanani V, Krebs CA. Duplex sonography of the portal venous system: pitfalls and limitations. AJR Am J Roentgenol 1989, 152:765-770. 10.2214/ajr.152.4.765, 2646868.
194. Taffoni MJ, Ravenel JG, Ackerman SJ. Prospective comparison of indirect CT venography versus venous sonography in ICU patients. AJR Am J Roentgenol 2005, 185:457-462. 10.2214/ajr.185.2.01850457, 16037520.
195. Menegatti E, Genova V, Tessari M, Malagoni AM, Bartolomei I, Zuolo M, Galeotti R, Salvi F, Zamboni P. The reproducibility of colour Doppler in chronic cerebrospinal venous insufficiency associated with multiple sclerosis. Int Angiol 2010, 29:121-126.
196. Monti L, Menci E, Ulivelli M, Cerase A, Bartalini S, Piu P, Marotti N, Leonini S, Galluzzi P, Romano DG, Casasco AE, Venturi C. Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls. PLoS One 2011, 6:e25012. 10.1371/journal.pone.0025012, 3178581, 21966398.
197. Zamboni P, Consorti G, Galeotti R, Gianesini S, Menegatti E, Tacconi G, Carinci F. Venous collateral circulation of the extracranial cerebrospinal outflow routes. Curr Neurovasc Res 2009, 6:204-212. 10.2174/156720209788970054, 19534716.
198. Higgins JN, Pickard JD. Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 2004, 62:1907-1908. 10.1212/01.WNL.0000125285.44539.D7, 15159514.
199. Higgins JN, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 2002, 359:228-230. 10.1016/S0140-6736(02)07440-8, 11812561.
200. Moyer JH, Miller SI, Snyder H. Effect of increased jugular pressure on cerebral hemodynamics. J Appl Physiol 1954, 7:245-247.
201. Chai PJ, Skaryak LA, Ungerleider RM, Greeley WJ, Kern FH, Schulman SR, Hansell DR, Auten RL, Mahaffey SF, Meliones JN. Jugular ligation does not increase intracranial pressure but does increase bihemispheric cerebral blood flow and metabolism. Crit Care Med 1995, 23:1864-1871. 10.1097/00003246-199511000-00013, 7587263.
202. Bateman GA. Arterial inflow and venous outflow in idiopathic intracranial hypertension associated with venous outflow stenoses. J Clin Neurosci 2008, 15:402-408. 10.1016/j.jocn.2007.03.018, 18242091.